The Role of Ubiquitin Phosphorylation in Cellular Aging
泛素磷酸化在细胞衰老中的作用
基本信息
- 批准号:9165414
- 负责人:
- 金额:$ 22.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAffectAgingAmino AcidsAmyotrophic Lateral SclerosisBiochemicalCell AgingCell physiologyCellsCritical PathwaysDataDecision MakingDegradation PathwayDevelopmentExhibitsFoundationsFunctional disorderGeneticGenetic ScreeningGoalsHomeostasisHumanHuntington DiseaseIn VitroLeadLongevityMediatingMembrane Protein TrafficMetabolismMitoticNerve DegenerationNeurodegenerative DisordersPathway interactionsPeptidesPhenotypePhosphorylationPhosphotransferasesPlayPositioning AttributePost-Translational Protein ProcessingProteinsProteomeProteomicsReagentRegulationResearchRoleSerineSignal PathwaySignal TransductionSystemTestingTherapeuticTimeUbiquitinUbiquitinationWorkYeastscell agegenetic analysisimprovedmulticatalytic endopeptidase complexnovelprotein degradationprotein misfoldingresearch studyscreeningtool
项目摘要
Project Summary
One of the cellular hallmarks of aging and neurodegeneration is a general decline in the protein
degradation capacity of the cell, resulting in the accumulation of damaged and misfolded proteins which can
threaten cellular integrity and viability. A key player in most cellular degradation pathways is ubiquitin – a 76
amino acid peptide that is covalently conjugated to proteins in order to target their degradation. Despite its
central role in global protein stability we know very little about the regulation of ubiquitin itself. Thus, there is a
critical need to understand the basic biochemical mechanisms responsible for regulating ubiquitin metabolism
and to explore the relationship between ubiquitin homeostasis and cellular aging. Recently, we identified a
novel signaling mechanism in yeast which regulates ubiquitin metabolism in the cell by controlling the
phosphorylation of ubiquitin itself. Importantly, we have found that yeast cells expressing phosphomimetic
ubiquitin exhibit a significantly extended post-mitotic lifespan. Given our preliminary results, we hypothesize
that phosphorylation of ubiquitin not only alters its metabolism but generally accelerates global protein
degradation and in doing so extends the post-mitotic life span of the cell. The experiments outlined in this
proposal will explore this hypothesis in the following specific aims:
Aim 1. Determine how ubiquitin phosphorylation extends yeast life span. We hypothesize that the life
span extension associated with ubiquitin phosphorylation is due to a global increase in protein degradation. To
test this, we will perform genetic analysis to define the degradation pathway that confers life span extension in
the presence of phospho-ubiquitin. We will also leverage newly-developed reagents to define and quantify
how ubiquitin phosphorylation affects the ubiquitin-modified proteome and how such changes may finely tune
the activity of the ubiquitin-proteasome system during an aging time course. These experiments will elucidate
the biochemical mechanism of life span extension associated with ubiquitin phosphorylation.
Aim 2. Identify ubiquitin kinases and test their ability to modulate yeast aging. We hypothesize that the
kinase activity responsible for Ser57 phosphorylation of ubiquitin will also play an important role in yeast
chronological aging. To identify yeast ubiquitin kinase(s), we will adopt both genetic and biochemical
screening approaches. Candidate kinases will be tested for membrane trafficking and cellular aging
phenotypes. Identification of the yeast ubiquitin kinase(s) will significantly advance our understanding of
ubiquitin metabolism and its relationship to the regulation of membrane traffic and post-mitotic aging.
Together, the experiments outlined in this proposal have a strong potential to define the relationship
between ubiquitin homeostasis, global protein stability, and cellular aging. Ultimately, this will contribute to our
understanding of longevity in post-mitotic cells and may lead to the identification of new pathways that
generally alter global protein stability.
项目概要
衰老和神经退行性变的细胞标志之一是蛋白质的普遍下降
细胞的降解能力,导致受损和错误折叠蛋白质的积累,
大多数细胞降解途径中的关键角色是泛素 – a 76。
与蛋白质共价结合的氨基酸肽,以靶向其降解。
泛素在整体蛋白质稳定性中的核心作用我们对泛素本身的调节知之甚少。
迫切需要了解负责调节泛素代谢的基本生化机制
为了探索泛素稳态与细胞衰老之间的关系,我们最近发现了一个。
酵母中的新信号传导机制,通过控制细胞中的泛素代谢来调节
重要的是,我们发现酵母细胞表达磷酸化模拟物。
鉴于我们的初步结果,泛素表现出显着延长的有丝分裂后寿命。
泛素的磷酸化不仅改变其新陈代谢,而且通常会加速整体蛋白质
降解并以此延长细胞有丝分裂后的寿命。
提案将在以下具体目标中探讨这一假设:
目标 1. 确定泛素磷酸化如何延长酵母寿命。
与泛素磷酸化相关的跨度扩展是由于蛋白质降解的整体增加。
对此进行测试,我们将进行遗传分析,以确定延长寿命的降解途径
我们还将利用新开发的试剂来定义和量化磷酸泛素的存在。
泛素磷酸化如何影响泛素修饰的蛋白质组以及这些变化如何进行微调
这些实验将阐明衰老过程中泛素蛋白酶体系统的活性。
与泛素磷酸化相关的寿命延长的生化机制。
目标 2. 鉴定泛素激酶并测试其调节酵母衰老的能力。
负责泛素 Ser57 磷酸化的激酶活性也将在酵母中发挥重要作用
为了识别酵母泛素激酶,我们将采用遗传和生物化学方法。
将测试候选激酶的膜运输和细胞老化。
表型的鉴定将显着增进我们对酵母泛素激酶的理解。
泛素代谢及其与膜交通调节和有丝分裂后衰老的关系。
总之,该提案中概述的实验具有定义这种关系的强大潜力
最终,这将有助于我们的泛素稳态、整体蛋白质稳定性和细胞衰老。
了解有丝分裂后细胞的寿命,并可能导致识别新的途径
通常会改变整体蛋白质的稳定性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason A MacGurn其他文献
Jason A MacGurn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason A MacGurn', 18)}}的其他基金
Deciphering the ubiquitin code in stress signaling and membrane trafficking
破译应激信号传导和膜运输中的泛素代码
- 批准号:
10330680 - 财政年份:2022
- 资助金额:
$ 22.13万 - 项目类别:
Deciphering the ubiquitin code in stress signaling and membrane trafficking
破译应激信号传导和膜运输中的泛素代码
- 批准号:
10557826 - 财政年份:2022
- 资助金额:
$ 22.13万 - 项目类别:
The Role of Ubiquitin Phosphorylation in Cellular Aging
泛素磷酸化在细胞衰老中的作用
- 批准号:
9322424 - 财政年份:2016
- 资助金额:
$ 22.13万 - 项目类别:
Molecular Mechanisms for Regulation of Ubiquitin Metabolism
泛素代谢调节的分子机制
- 批准号:
9252906 - 财政年份:2016
- 资助金额:
$ 22.13万 - 项目类别:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
Nedd4 家族泛素连接酶的底物靶向机制
- 批准号:
8786568 - 财政年份:2012
- 资助金额:
$ 22.13万 - 项目类别:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
Nedd4 家族泛素连接酶的底物靶向机制
- 批准号:
8279635 - 财政年份:2012
- 资助金额:
$ 22.13万 - 项目类别:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
Nedd4 家族泛素连接酶的底物靶向机制
- 批准号:
8474635 - 财政年份:2012
- 资助金额:
$ 22.13万 - 项目类别:
Substrate Targeting Mechanisms of Nedd4 Family Ubiquitin Ligases
Nedd4 家族泛素连接酶的底物靶向机制
- 批准号:
8776479 - 财政年份:2012
- 资助金额:
$ 22.13万 - 项目类别:
相似国自然基金
htsA蛋白通过影响碳水化合物摄取抵抗宿主免疫杀伤的机制研究
- 批准号:82302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
WASP通过影响IL-6R内吞调控Tfh发育和功能
- 批准号:82302055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脱氧胆酸通过c-Abl-YAP通路调控肠粘膜屏障功能对肝脂肪变形成影响
- 批准号:82370558
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
四君子汤通过调节胃粘膜逆生细胞命运影响胃癌前疾病与胃癌发生的作用与机制研究
- 批准号:82373110
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肠罗斯拜瑞氏菌通过丙酸失活酪氨酸激酶JAK2影响STAT3磷酸化阻抑UC肠道纤维化的分子机制研究
- 批准号:82370539
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 22.13万 - 项目类别:
Paid Sick Leave Mandates and Mental Healthcare Service Use
带薪病假规定和心理保健服务的使用
- 批准号:
10635492 - 财政年份:2023
- 资助金额:
$ 22.13万 - 项目类别:
Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting
无线无导管尿动力学在家庭环境中进行扩展、综合泌尿外科评估的临床可行性
- 批准号:
10762486 - 财政年份:2023
- 资助金额:
$ 22.13万 - 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
- 批准号:
10726660 - 财政年份:2023
- 资助金额:
$ 22.13万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 22.13万 - 项目类别: